- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | ENvue Medical resumes PainShield shipments from U.S. facility | 1 | Investing.com | ||
| 02.09. | ENvue Medical, Inc.: ENvue Medical Selected to Exhibit ENvue Navigation Platform at Vizient Innovative Technology Exchange | 1 | GlobeNewswire (USA) | ||
| 01.09. | XFRA 56R: AUSSETZUNG/SUSPENSION | 239 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILENVUE MED INC. NEW... ► Artikel lesen | |
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 01.09. | XFRA NEW INSTRUMENTS AVAILABLE ON 01.09.2026 | 166 | Xetra Newsboard | The following instruments on XETRA do have their first trading 01.09.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 01.09.2026
Aktien
1 VGG863021256 SWVL Holdings Corp.
2... ► Artikel lesen | |
| 31.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 31.08.2026 | 657 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 31.08.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 31.08.2026ISIN NameDE000A0N3UD5 ROSTRA... ► Artikel lesen | |
| 31.08. | XFRA ISIN CHANGE | 196 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS63008J8844 ENvue Medical Inc. 31.08.2026 US63008J8760 ENvue Medical Inc. 01.09.2026 Tausch 12:1 ► Artikel lesen | |
| 28.08. | ENvue Medical announces 1-for-12 reverse stock split | 6 | Investing.com | ||
| 28.08. | ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split | 190 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that a reverse stock split... ► Artikel lesen | |
| 19.08. | ENvue Medical: Revenue Jumps 275% As Hospital Adoption Offsets PainShield Production Shutdown | 5 | pulse2.com | ||
| 18.08. | ENvue Medical, Inc.: ENvue Medical Announces Exclusive UroShield Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million | 199 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced a new exclusive distribution agreement... ► Artikel lesen | |
| 17.08. | ENvue Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.08. | ENvue Medical secures up to $50M equity facility to fund growth plans | 3 | Seeking Alpha | ||
| 12.08. | ENvue Medical secures $50M equity financing facility | 5 | Investing.com | ||
| 12.08. | ENvue Medical, Inc.: ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions | 319 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into... ► Artikel lesen | |
| 12.08. | ENvue Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.08. | ENvue Medical completes US manufacturing transition | 1 | Investing.com | ||
| 04.08. | ENvue Medical, Inc.: ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities | 247 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced it has completed the transition... ► Artikel lesen | |
| 23.07. | ENvue Medical, Inc.: ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center | 1 | GlobeNewswire (USA) | ||
| 15.07. | ENvue Medical names new chairman, adds two directors | 5 | Investing.com | ||
| 15.07. | ENvue Medical, Inc.: ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform | 479 | GlobeNewswire (Europe) | Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing... ► Artikel lesen |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 38,230 | -0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| TELADOC HEALTH | 5,328 | +0,38 % | Here's Why Teladoc's Integrated Care Business Deserves More Attention | ||
| SERNOVA BIOTHERAPEUTICS | 0,083 | -3,27 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| BECTON DICKINSON | 151,70 | -1,04 % | Dividendenbekanntmachungen (09.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0,319 HKD 0,0349 EUR ANHUI CONCH CEMENT CO LTD ADR US0352431045 0,0958 USD 0,0824... ► Artikel lesen | |
| CERENOME | 2,020 | -2,65 % | Cerenome, Inc.: Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment | Capital will support continued CNSide commercial scale-up and development Initial tranche of funding provided at closing with future tranches linked to milestones Forecasted cash runway now into 2028... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,060 | -4,63 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SPINEWAY | 0,111 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 15,800 | +6,76 % | Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now | ||
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| CO-DIAGNOSTICS | 1,120 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| QUIDELORTHO | 9,962 | -2,43 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,435 | -0,20 % | Veru Inc.: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial | ||
| LIFEWARD | 7,120 | -1,11 % | Lifeward Ltd.: Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy |
ENVUE MEDICAL INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,070 (+1,96 %) liegt der Kurs bei 3,650 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVUE MEDICAL INC finden Sie auf Wallstreet Online.